You are here

  • Home
  • Archive
  • Volume 11, Issue 1
  • Association of immune-related adverse events with the outcomes of immune checkpoint inhibitors in patients with dMMR/MSI-H metastatic colorectal cancer

Article metrics

Article menu
Immunotherapy biomarkers
Original research
Association of immune-related adverse events with the outcomes of immune checkpoint inhibitors in patients with dMMR/MSI-H metastatic colorectal cancer

 

Online download statistics by month:

Online download statistics by month: January 2023 to March 2026

AbstractFullPdf
Jan 2023913922261
Feb 202322222263
Mar 202317217455
Apr 202318018645
May 202317117539
Jun 202313513625
Jul 202313313451
Aug 202315716128
Sep 202310911028
Oct 202310711236
Nov 202312012128
Dec 2023687229
Jan 2024737457
Feb 2024808239
Mar 2024606258
Apr 2024394242
May 2024555739
Jun 2024626137
Jul 2024747536
Aug 2024525122
Sep 2024707244
Oct 2024687822
Nov 2024484930
Dec 2024667940
Jan 2025606029
Feb 202513613637
Mar 2025949462
Apr 202510810850
May 2025646943
Jun 2025444422
Jul 2025110
Mar 2026110
Total374238201397